We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+16.18%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.27B
AUM Growth
+$164M
Cap. Flow
+$6.25M
Cap. Flow %
0.49%
Top 10 Hldgs %
32.1%
Holding
194
New
16
Increased
56
Reduced
68
Closed
2

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$13.7M
2
RTX icon
RTX Corp
RTX
+$5.49M
3
HXL icon
Hexcel
HXL
+$2.98M
4
CVX icon
Chevron
CVX
+$1.29M
5
USB icon
US Bancorp
USB
+$1.19M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$2.21M
3
PYPL icon
PayPal
PYPL
+$1.94M
4
EBAY icon
eBay
EBAY
+$1.91M
5
ADSK icon
Autodesk
ADSK
+$926K

Sector Composition

Rank Sector Weight
1 Technology 28.26%
2 Healthcare 15.73%
3 Financials 12.71%
4 Industrials 12.19%
5 Consumer Staples 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
76
Vertex Pharmaceuticals
VRTX
$124B
$1.85M 0.15%
7,843
+221
+3% +$50.7K
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.83M 0.14%
4,903
+1,511
+45% +$536K
ABT icon
78
Abbott
ABT
$187B
$1.81M 0.14%
16,505
HON icon
79
Honeywell
HON
$78.3B
$1.79M 0.14%
8,951
GOOGL icon
80
Alphabet (Google) Class A
GOOGL
$4.08T
$1.72M 0.14%
19,640
-400
-2% -$33.6K
GOOG icon
81
Alphabet (Google) Class C
GOOG
$4.07T
$1.6M 0.13%
18,240
NTR icon
82
Nutrien
NTR
$33.3B
$1.49M 0.12%
30,960
FAST icon
83
Fastenal
FAST
$55.2B
$1.46M 0.11%
59,712
AMZN icon
84
Amazon
AMZN
$2.48T
$1.43M 0.11%
8,800
-180
-2% -$28.7K
HD icon
85
Home Depot
HD
$343B
$1.38M 0.11%
5,188
+20
+0.4% +$5.5K
ISRG icon
86
Intuitive Surgical
ISRG
$130B
$1.26M 0.1%
4,638
JWN
87
DELISTED
Nordstrom
JWN
$1.24M 0.1%
39,714
-9,697
-20% -$203K
ADP icon
88
Automatic Data Processing
ADP
$106B
$1.17M 0.09%
6,663
ALXN
89
DELISTED
Alexion Pharmaceuticals
ALXN
$1.17M 0.09%
7,467
+300
+4% +$38.5K
BMY icon
90
Bristol-Myers Squibb
BMY
$130B
$1.15M 0.09%
18,533
+116
+0.6% +$7.13K
UNP icon
91
Union Pacific
UNP
$175B
$1.14M 0.09%
5,457
IONS icon
92
Ionis Pharmaceuticals
IONS
$9.14B
$1.11M 0.09%
19,642
+605
+3% +$30.1K
EMR icon
93
Emerson Electric
EMR
$85B
$1.1M 0.09%
13,725
-50
-0.4% -$3.72K
INCY icon
94
Incyte
INCY
$26B
$1.09M 0.09%
12,535
+359
+3% +$31.1K
NBIX icon
95
Neurocrine Biosciences
NBIX
$18.4B
$1.09M 0.09%
11,379
+262
+2% +$25.3K
KMB icon
96
Kimberly-Clark
KMB
$37.5B
$1.08M 0.08%
8,005
+85
+1% +$11.9K
V icon
97
Visa
V
$697B
$1.03M 0.08%
4,723
-105
-2% -$21.5K
TSLA icon
98
Tesla
TSLA
$1.21T
$1.02M 0.08%
4,329
-66
-2% -$11.3K
VPL icon
99
Vanguard FTSE Pacific ETF
VPL
$7.89B
$1M 0.08%
12,610
BMRN icon
100
BioMarin Pharmaceuticals
BMRN
$12B
$990K 0.08%
11,239
+439
+4% +$34.8K

Similar funds

Grandfield & Dodd's Q4 2020 Portfolio in Review

As of Q4 2020, Grandfield & Dodd held 194 positions worth $1.27B, up 15% from $1.11B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q4 2020 filing shows 16 new, 56 increased, 68 reduced and 2 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 2,012 shares worth $620K. The largest sale was Unilever NV New York Registry Shares, an estimated $13.3M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q4 2020 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 2,012 shares worth $620K.
  • Grandfield & Dodd added most to Unilever in Q4 2020, an estimated $13.7M increase.
  • Grandfield & Dodd's biggest Q4 2020 reduction was Microsoft, cutting an estimated $2.21M.
  • Grandfield & Dodd fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $13.3M.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.27B portfolio in Q4 2020.
  • Grandfield & Dodd opened 16 new positions and closed 2 in Q4 2020.
  • Grandfield & Dodd's portfolio value rose 15% quarter-over-quarter to $1.27B.

Based on Grandfield & Dodd's 13F filing for Q4 2020, filed 29 Jan 2021.